サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1587830

顧みられない熱帯病治療の市場規模、シェア、動向分析レポート：疾患別、製品別、地域別、セグメント別予測、2024年～2030年

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
顧みられない熱帯病治療の市場規模、シェア、動向分析レポート：疾患別、製品別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年10月03日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顧みられない熱帯病治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の顧みられない熱帯病治療市場規模は、予測期間中にCAGR 4.8％で拡大し、2030年までに52億5,000万米ドルに達する見込みです。

顧みられない熱帯病の有病率の増加は、重要な影響レンダリングドライバーであると考えられています。

2018年にWHOで発表されたデータによると、T.B. Gambienseは中央と西アフリカの24カ国で流行しています。これにより、報告されている眠り病の症例の約98％が引き起こされています。さらに、CDCによると、デング熱によって年間約400人が感染しています。

さらに、WHOが2019年に発表した統計によると、世界人口の24％にあたる15億人以上が土壌伝染性蠕虫症に感染しています。これらの感染症は熱帯・亜熱帯地域に広く分布し、主にアメリカ、サハラ以南のアフリカ、東アジア、中国で発生しています。

パイプラインのワクチンや薬剤の存在も、予測期間中の市場成長を促進する主要要因の1つと考えられています。例えば、Bayer AGは、シャーガス病治療として現在第III相臨床検査中のニフルチモックス（BAYA2502）を開発しています。さらに、Johnson & Johnson Services Inc.は、ハンセン病治療として第II相臨床検査中のベダキリン200mg単剤レジメンを開発しており、この検査は2021年に完了すると推定されています。

さらに、Instituto ButantanとMerck &Co, Inc.は2018年、デング熱に対するワクチン開発で協力しました。Instituto Butantanはブラジルでデング熱ワクチン候補であるTV003を開発しており、現在進行中の第3相臨床検査中です。Merck & Co., Inc.はInstituto Butantanに開発資金を記載しています。

F. Hoffmann-La Roche Ltd、Bayer AG、GlaxoSmithKline plc、Novartis AG、Pfizer, Inc.、Eisai Co. Ltd.、Sanofi,、Astellas Pharma、Takeda Pharmaceutical Company Limited、Gilead Sciencesが市場全体の成長に拍車をかけると予想されています。これらの企業が新製品市場開拓に関与していることが、熱帯病治療市場の成長要因であると考えられています。

熱帯病治療市場のレポートハイライト

  • デング熱は、その有病率の増加により、2023年に最大のセグメントシェアを占めました。
  • ブルーリ潰瘍は、この疾患に対する意識の高まりにより、予測期間中に最も急成長するセグメントと予測されます。
  • 2023年には、薬剤が最大の製品セグメントになると予測されます。
  • ワクチンは、パイプライン製品の強い存在感により、予測期間中に最も急成長するセグメントと推定されます。
  • 2023年には、アジア太平洋が顧みられない熱帯病治療市場を独占しました。
  • ラテンアメリカは予測期間中に最も急成長すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 顧みられない熱帯病治療市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 顧みられない熱帯病治療市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 顧みられない熱帯病治療市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • 顧みられない熱帯病治療市場：製品変動分析、100万米ドル、2023年と2030年
  • 薬剤
    • 寄生虫駆除
    • 抗真菌
    • 抗生物質
    • その他
  • ワクチン

第5章 顧みられない熱帯病治療市場：疾患別、推定・動向分析

  • セグメントダッシュボード
  • 顧みられない熱帯病治療市場：疾患変動分析、100万米ドル、2023年と2030年
  • デング熱
  • 狂犬病
  • トラコーマ
  • ブルーリ潰瘍
  • イチゴ腫
  • ハンセン病
  • シャーガス病
  • ヒトアフリカトリパノソーマ症
  • リーシュマニア症

第6章 顧みられない熱帯病治療市場：地域別、推定・動向分析

  • 顧みられない熱帯病治療の市場シェア、地域別、2023年と2030年、100万米ドル。
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer, Inc
    • Eisai Co. Ltd.
    • Sanofi.
    • Astellas Pharma
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences
図表

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 North America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 3 North America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 4 U.S. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 5 U.S. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 6 Canada Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 7 Canada Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 8 Europe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 9 Europe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 10 U.K. Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 11 U.K. Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 12 Germany Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 13 Germany Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 14 Asia Pacific Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 15 Asia Pacific Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 16 Japan Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 17 Japan Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 18 China Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 19 China Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 20 India Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 21 India Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 22 Indonesia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 23 Indonesia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 24 Singapore Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 25 Singapore Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 26 Philippines Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 27 Philippines Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 28 Latin America Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 29 Latin America Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 30 Mexico Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 31 Mexico Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 32 Brazil Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 33 Brazil Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 34 Argentina Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 35 Argentina Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 36 Colombia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 37 Colombia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 38 Bolivia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 39 Bolivia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 40 MEA Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 41 MEA Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 42 South Africa Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 43 South Africa Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 44 Saudi Arabia Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 46 UAE Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 47 UAE Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 48 Nigeria Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 49 Nigeria Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 50 Ghana Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 51 Ghana Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)
  • TABLE 52 Zimbabwe Neglected Tropical Disease Treatment Market, By Disease, 2018 - 2030 (USD Million)
  • TABLE 53 Zimbabwe Neglected Tropical Disease Treatment Market, By Product Type, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global Neglected Tropical Disease Treatment market- Key market driver analysis
  • FIG. 7 Global Neglected Tropical Disease Treatment market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global Neglected Tropical Disease Treatment market - Porter's analysis
  • FIG. 10 Global Neglected Tropical Disease Treatment market - PESTEL analysis
  • FIG. 11 Global Neglected Tropical Disease Treatment market disease outlook key takeaways
  • FIG. 12 Global Neglected Tropical Disease Treatment market: Disease movement analysis
  • FIG. 13 Dengue market estimates, 2018 - 2030 (USD Million)
  • FIG. 14 Rabies market estimates, 2018 - 2030 (USD Million)
  • FIG. 15 Trachoma market estimates, 2018 - 2030 (USD Million)
  • FIG. 16 Buruli ulcer market estimates, 2018 - 2030 (USD Million)
  • FIG. 17 Yaw's market estimates, 2018 - 2030 (USD Million)
  • FIG. 18 Leprosy market estimates, 2018 - 2030 (USD Million)
  • FIG. 19 Chagas disease market estimates, 2018 - 2030 (USD Million)
  • FIG. 20 Human African trypanosomiasis (sleeping sickness) market estimates, 2018 - 2030 (USD Million)
  • FIG. 21 Leishmaniases market estimates, 2018 - 2030 (USD Million)
  • FIG. 22 Soil-transmitted helminthiases market estimates, 2018 - 2030 (USD Million)
  • FIG. 23 Others market estimates, 2018 - 2030 (USD Million)
  • FIG. 24 Global Neglected Tropical Disease Treatment market Product type outlook key takeaways
  • FIG. 25 Global Neglected Tropical Disease Treatment market: Product type movement analysis
  • FIG. 26 Drugs market estimates, 2018 - 2030 (USD Million)
  • FIG. 27 Vaccines market estimates, 2018 - 2030 (USD Million)
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 Global Neglected Tropical Disease Treatment market: Regional movement analysis
  • FIG. 30 North America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 31 U.S. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 32 Canada Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 33 Europe Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 34 U.K. Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 35 Germany Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 36 Asia Pacific Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 37 Japan Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 38 China Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 39 India Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 40 Indonesia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 41 Singapore Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 42 Philippines Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 43 Latin America Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG 44 Brazil Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 45 Mexico Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 46 Argentina Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 47 Colombia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 48 Bolivia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million
  • FIG. 49 MEA Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 50 South Africa Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 51 Saudi Arabia Neglected Tropical Disease Treatment market, 2018 - 2030 (USD Million)
  • FIG. 52 UAE market, 2018 - 2030 (USD Million)
  • FIG. 53 Nigeria market, 2018 - 2030 (USD Million)
  • FIG. 54 Ghana market, 2018 - 2030 (USD Million)
  • FIG. 55 Zimbabwe market, 2018 - 2030 (USD Million)
  • FIG. 56 Strategy framework
目次
Product Code: GVR-3-68038-787-2

Neglected Tropical Disease Treatment Market Growth & Trends:

The global neglected tropical disease treatment market size is expected to reach USD 5.25 billion by 2030, expanding at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of neglected tropical diseases is considered to be the vital impact rendering driver.

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world's population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Presence of key players such as F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited, and Gilead Sciences is expected to fuel to the overall market growth. Involvement of these players in new product development is considered to be the contributing factor for the NTD treatment market.

Tropical Disease Treatment Market Report Highlights:

  • Dengue held the largest segment share in 2023 owing to its increasing prevalence rate
  • Buruli ulcer is estimated to be the fastest growing segment over the forecast period owing to rising awareness about the disease
  • In 2023, drugs were anticipated to be the largest product segment
  • Vaccines are estimated to be the fastest growing segment over the forecast period due to strong presence of pipeline products
  • Asia Pacific dominated the neglected tropical disease treatment market in 2023
  • Latin America is estimated to witness the fastest growth over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neglected Tropical Disease Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neglected Tropical Disease Treatment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neglected Tropical Disease Treatment Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Drugs
    • 4.3.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-Parasite
      • 4.3.2.1. Anti-Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Antifungal
      • 4.3.3.1. Antifungal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Antibiotics
      • 4.3.4.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Vaccines
    • 4.4.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neglected Tropical Disease Treatment Market: Disease Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Dengue
    • 5.3.1. Dengue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Rabies
    • 5.4.1. Rabies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Trachoma
    • 5.5.1. Trachoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Buruli Ulcer
    • 5.6.1. Buruli Ulcer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Yaws
    • 5.7.1. Yaws Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Leprosy
    • 5.8.1. Leprosy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Chagas Disease
    • 5.9.1. Chagas Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Human African Trypanosomiasis
    • 5.10.1. Human African Trypanosomiasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Leishmaniases
    • 5.11.1. Leishmaniases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Neglected Tropical Disease Treatment Market Share, By Region, 2023 & 2030, USD Million.
  • 6.2. North America
    • 6.2.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UAE
      • 6.6.2.1. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Bayer AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. GlaxoSmithKline plc
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Novartis AG
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Pfizer, Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Eisai Co. Ltd.,
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Sanofi.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Astellas Pharma
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Takeda Pharmaceutical Company Limited
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Gilead Sciences
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives